Genentech Clinical Trials A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) Condition: Hepatocellular Carcinoma (HCC) Drugs:Tiragolumab Trial Name:CO44668 Age:≥18 Years Phase:3 Contact Us